Rafael Moreno

1.8k total citations
49 papers, 1.2k citations indexed

About

Rafael Moreno is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Rafael Moreno has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 27 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Rafael Moreno's work include Virus-based gene therapy research (35 papers), CAR-T cell therapy research (23 papers) and Cancer Research and Treatments (15 papers). Rafael Moreno is often cited by papers focused on Virus-based gene therapy research (35 papers), CAR-T cell therapy research (23 papers) and Cancer Research and Treatments (15 papers). Rafael Moreno collaborates with scholars based in Spain, Sweden and United States. Rafael Moreno's co-authors include Ramón Alemany, Carlos Alberto Fajardo, Jana de Sostoa, Luis A. Rojas, Martí Farrera-Sal, Manel Cascalló, Marcel Arias-Badia, Josep M. Aran, María Dolores Burguete Ramos and Xavier Corbella and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rafael Moreno

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael Moreno Spain	20	636	628	491	257	175	49	1.2k
Yosuke Kawakami Japan	19	468 0.7×	617 1.0×	556 1.1×	122 0.5×	108 0.6×	42	1.1k
Tanja Hakkarainen Finland	23	639 1.0×	949 1.5×	847 1.7×	109 0.4×	247 1.4×	36	1.4k
Ángel A. Rivera United States	24	737 1.2×	1.1k 1.7×	1.1k 2.2×	152 0.6×	214 1.2×	46	1.7k
Alex W. Tong United States	16	448 0.7×	464 0.7×	644 1.3×	298 1.2×	172 1.0×	26	1.2k
George R. Gunn United States	11	475 0.7×	193 0.3×	432 0.9×	547 2.1×	168 1.0×	21	1.3k
R C Moen United States	13	699 1.1×	1.2k 1.9×	1.2k 2.5×	354 1.4×	98 0.6×	20	2.3k
Jean‐Marc Limacher France	19	767 1.2×	381 0.6×	583 1.2×	482 1.9×	108 0.6×	44	1.4k
Anne I.J. Arens Netherlands	18	552 0.9×	466 0.7×	897 1.8×	129 0.5×	33 0.2×	49	1.6k
Melinda VanRoey United States	18	768 1.2×	412 0.7×	707 1.4×	552 2.1×	124 0.7×	21	1.4k
Brian Barnett United States	15	542 0.9×	358 0.6×	383 0.8×	565 2.2×	68 0.4×	34	1.2k

Countries citing papers authored by Rafael Moreno

Since Specialization

Citations

This map shows the geographic impact of Rafael Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Moreno more than expected).

Fields of papers citing papers by Rafael Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Moreno. The network helps show where Rafael Moreno may publish in the future.

Co-authorship network of co-authors of Rafael Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Moreno. A scholar is included among the top collaborators of Rafael Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Moreno. Rafael Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muro, Xavier García del, Begoña P. Valderrama, Ana Medina, et al.. (2025). Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial. Clinical Cancer Research. 31(4). 659–666. 1 indexed citations

Costa-García, Marcel, et al.. (2024). Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors. Cancer Immunology Immunotherapy. 73(1). 5–5. 4 indexed citations

García‐Mulero, Sandra, Marco Punta, Stefano Lise, et al.. (2023). Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients. OncoImmunology. 12(1). 2261278–2261278. 5 indexed citations

Jové, Maria, Irene Braña, María Victoria Maliandi, et al.. (2023). 937P Survival outcomes in phase I trial combining VCN-01 and durvalumab (MEDI4736) in subjects with recurrent/metastatic head and neck squamous cell carcinoma refractory to previous immunotherapy treatment. Annals of Oncology. 34. S589–S590. 1 indexed citations

Castillo, J.J. Soto, Rafael Moreno, Carles Codony, et al.. (2023). SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy. International Journal of Molecular Sciences. 24(13). 11143–11143. 4 indexed citations

Wenthe, Jessica, Rafael Moreno, Gustav Ullenhag, et al.. (2022). Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition. Molecular Therapy — Oncolytics. 24. 429–442. 11 indexed citations

Farrera-Sal, Martí, Giancarlo Castellano, Rafael Moreno, et al.. (2021). Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses. NAR Cancer. 3(2). zcab015–zcab015. 6 indexed citations

Farrera-Sal, Martí, Rafael Moreno, Ana Mato-Berciano, et al.. (2021). Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation. Molecular Therapy — Oncolytics. 22. 27–35. 23 indexed citations

Farrera-Sal, Martí, Jana de Sostoa, Rafael Moreno, et al.. (2020). Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness. International Journal of Molecular Sciences. 21(14). 5158–5158. 6 indexed citations

10.

Sostoa, Jana de, Carlos Alberto Fajardo, Rafael Moreno, et al.. (2019). Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager. Journal for ImmunoTherapy of Cancer. 7(1). 19–19. 129 indexed citations

11.

Moreno, Rafael, Carlos Alberto Fajardo, Martí Farrera-Sal, et al.. (2018). Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells. Molecular Cancer Therapeutics. 18(1). 127–138. 39 indexed citations

12.

García, Margarita, Rafael Moreno, Marta Gil-Martín, et al.. (2018). A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. Human Gene Therapy. 30(3). 352–364. 80 indexed citations

13.

Fajardo, Carlos Alberto, Sònia Guedan, Luis A. Rojas, et al.. (2017). Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy. Cancer Research. 77(8). 2052–2063. 130 indexed citations

14.

Rojas, Luis A., Gabriela N. Condezo, Rafael Moreno, et al.. (2016). Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery. Journal of Controlled Release. 237. 78–88. 50 indexed citations

15.

Rodríguez-García, Alba, Marta Giménez-Alejandre, Juan J. Rojas, et al.. (2014). Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression. Clinical Cancer Research. 21(6). 1406–1418. 87 indexed citations

16.

Martínez-González, Itziar, María Jesús Cruz, Rafael Moreno, et al.. (2014). Human Mesenchymal Stem Cells Resolve Airway Inflammation, Hyperreactivity, and Histopathology in a Mouse Model of Occupational Asthma. Stem Cells and Development. 23(19). 2352–2363. 19 indexed citations

17.

Martínez-González, Itziar, Oriol Roca, Joan Ramón Masclans, et al.. (2013). Human Mesenchymal Stem Cells Overexpressing the IL-33 Antagonist Soluble IL-1 Receptor–Like–1 Attenuate Endotoxin-Induced Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 49(4). 552–562. 74 indexed citations

18.

Moreno, Rafael, Itziar Martínez-González, Marga Nadal, et al.. (2011). Fetal Liver-Derived Mesenchymal Stem Cell Engraftment After Allogeneic In Utero Transplantation into Rabbits. Stem Cells and Development. 21(2). 284–295. 12 indexed citations

19.

Moreno, Rafael, et al.. (2010). Characterization of Mesenchymal Stem Cells Isolated from the Rabbit Fetal Liver. Stem Cells and Development. 19(10). 1579–1588. 25 indexed citations

20.

Moreno, Rafael, Itziar Martínez-González, Jordi Pétriz, et al.. (2010). The β-Interferon Scaffold Attachment Region Confers High-Level Transgene Expression and Avoids Extinction by Epigenetic Modifications of Integrated Provirus in Adipose Tissue-Derived Human Mesenchymal Stem Cells. Tissue Engineering Part C Methods. 17(3). 275–287. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact